Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pds Biotechnology Corp (PDSB)

Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 61,725
  • Shares Outstanding, K 37,409
  • Annual Sales, $ 0 K
  • Annual Income, $ -42,940 K
  • EBIT $ -39 M
  • EBITDA $ -39 M
  • 60-Month Beta 1.85
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.93

Options Overview Details

View History
  • Implied Volatility 161.95% ( -227.04%)
  • Historical Volatility 95.19%
  • IV Percentile 59%
  • IV Rank 31.86%
  • IV High 477.58% on 08/08/24
  • IV Low 14.38% on 06/10/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 186
  • Volume Avg (30-Day) 225
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 4,988
  • Open Int (30-Day) 3,432

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.31
  • Number of Estimates 3
  • High Estimate -0.29
  • Low Estimate -0.34
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +8.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6300 +1.23%
on 12/20/24
2.4600 -32.93%
on 12/04/24
-0.3750 (-18.52%)
since 11/20/24
3-Month
1.5300 +7.84%
on 11/14/24
4.2900 -61.54%
on 10/03/24
-1.5500 (-48.44%)
since 09/20/24
52-Week
1.5300 +7.84%
on 11/14/24
6.6800 -75.30%
on 03/04/24
-3.2100 (-66.05%)
since 12/20/23

Most Recent Stories

More News
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PDSB : 1.6500 (-5.71%)
PDS Biotechnology Corporation Announces Key Opinion Leader Event on HPV16-Positive Head and Neck Cancer and Phase 3 Clinical Trial for Versamune® HPV

PDS Biotech announces KOL event to discuss HPV16-positive HNSCC and upcoming clinical trial for Versamune® HPV therapy.Quiver AI SummaryPDS Biotechnology Corporation announced a Key Opinion Leader (KOL)...

PDSB : 1.6500 (-5.71%)
PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET

PDSB : 1.6500 (-5.71%)
PDS Biotechnology: Q3 Earnings Snapshot

PDS Biotechnology: Q3 Earnings Snapshot

PDSB : 1.6500 (-5.71%)
PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results

PDSB : 1.6500 (-5.71%)
PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time

PDSB : 1.6500 (-5.71%)
PDS Biotech Announces Presentation of Rationale and Design of First Recurrent Prostate Cancer Trial to Combine an Androgen Receptor Pathway Inhibitor with an Immunocytokine

PDSB : 1.6500 (-5.71%)
PDS Biotechnology: Q2 Earnings Snapshot

PDS Biotechnology: Q2 Earnings Snapshot

PDSB : 1.6500 (-5.71%)
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults

/CNW/ -- USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale...

ONCY : 0.8310 (-6.36%)
TCRX : 2.97 (+1.37%)
BMY : 57.33 (+1.83%)
PDSB : 1.6500 (-5.71%)
CCCC : 3.95 (+2.73%)
ONC.TO : 1.19 (-9.16%)
Global Efforts Intensify to Address Surging Young Adult Colorectal and Anal Cancer Rates

USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale Medicine. As well, there are now alarming reports around...

ONCY : 0.8310 (-6.36%)
ONC.TO : 1.19 (-9.16%)
TCRX : 2.97 (+1.37%)
BMY : 57.33 (+1.83%)
PDSB : 1.6500 (-5.71%)
CCCC : 3.95 (+2.73%)

Business Summary

PDS Biotechnology Corp. is an immuno-oncology company. It is focused on developing a pipeline of clinical-stage immunotherapies to treat cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, cancer and other cancers. The company's products are based on the proprietary...

See More

Key Turning Points

3rd Resistance Point 1.9405
2nd Resistance Point 1.8744
1st Resistance Point 1.7622
Last Price 1.6500
1st Support Level 1.5839
2nd Support Level 1.5178
3rd Support Level 1.4056

See More

52-Week High 6.6800
Fibonacci 61.8% 4.7127
Fibonacci 50% 4.1050
Fibonacci 38.2% 3.4973
Last Price 1.6500
52-Week Low 1.5300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar